Introduction
============

The study and development of a novel drug is not only costly and time-consuming, but the safety and efficacy must be seriously considered, and determine the success of the drug. Thus, toxicity is one of the main reasons leading to the failure of drug development. The liver is considered as the most important organ in drug toxicity for as it is functionally interposed between the site of absorption and the systemic circulation, and is a major site of metabolism and elimination of foreign substances. However, these features also render it a preferred target for drug toxicity ([@b1-mmr-17-01-0743]). Drug-induced liver injury is one of the most common reasons that accounts for the attrition of candidate drugs during the later stages of drug development ([@b2-mmr-17-01-0743]). Consequently, early detection of drug-induced hepatotoxicity is essential before compounds are tested in animals and enter clinical trials, to save time and resources ([@b3-mmr-17-01-0743]).

Natural product extracts have long been implemented as therapeutics all over the world ([@b4-mmr-17-01-0743]). Since the discovery of penicillin, which was the first pure antibiotic isolated from the fungus *Penicillium rubens*, the industry for natural products developed in 1928 ([@b5-mmr-17-01-0743]). The ocean covers \>70% of the earth\'s surface, and the marine environment is home to a taxonomically diverse ecosystem full of bioactive natural products from diverse sources as microorganisms, invertebrates, plants and animals ([@b6-mmr-17-01-0743]). Organisms such as algae, mollusks, sponges, corals and tunicates have evolved to survive the high concentrations of infectious and surface-fouling bacteria that are indigenous to ocean waters. Marine microorganism has been recognized as a rich source of biological macromolecules and the search for bioactive compounds from marine organisms in recent decades has produced an abundance of extracts with pharmaceutical and industrial applications, such as food, cosmetics and pharmacology ([@b7-mmr-17-01-0743]).

Oxalicumone A (POA) is a constituent isolated from a culture broth of the South China Sea fungus *Penicillium oxalicum* SCSGAF 0023 ([@b8-mmr-17-01-0743]). Its chemical structure was first identified by Zhang *et al* ([@b9-mmr-17-01-0743]) ([Fig. 1](#f1-mmr-17-01-0743){ref-type="fig"}). POA demonstrates significant cytotoxicity against several human carcinoma cell lines with IC~50~ ≤10 µM ([@b8-mmr-17-01-0743]); therefore, it represents a potent anticancer bioactive agent. However, to the best of our knowledge, the influence of POA on healthy human cells remains to be investigated.

Therefore, the present study aimed to investigate the cytotoxic effects of POA on L-02 healthy human liver cells, and the underlying mechanisms, including apoptosis pathways, oxidative stress and mitochondrial function.

Materials and methods
=====================

### Chemicals

RPMI 1640 medium and fetal bovine serum (FBS) were purchased from Biological Industries USA (Cromwell, CT, USA) and *Bi*ological Industries Israel Beit-Haemek (Kibbutz Beit-Haemek, Israel), respectively. Cell Counting kit-8 (CCK-8) dye was purchased from Dojindo Molecular Technologies, Inc. (Kumamoto, Japan). Trypsin, dimethyl sulfoxide (DMSO) and Hoechst 33258 were purchased from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). The Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) double staining kit, cell cycle kit, 5,5,6,6-tetra-chloro-1,1,3,3-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) dye and caspase-3 activity assay kits were purchased from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China). Glutathione (GSH; cat. no. CEA294Ge) was purchased from Uscn Life Sciences, Inc. (Wuhan, China). Radioimmunoprecipitation assay (RIPA) lysis buffer and an Enhanced Chemiluminescence substrate kit were purchased from the Biomiga (San Diego, CA, USA) and Beyotime Institute of Biotechnology (Jiangsu, China), respectively. The bicinchoninic acid (BCA) protein assay kit was purchased from Bioteke Corporation (Beijing, China). Fas cell surface death receptor (Fas; dilution 1:4,000; cat. no. ab133619), B-cell lymphoma 2 (Bcl-2; dilution 1:4,000; cat. no. ab182858), Bcl-2 X-associated protein (Bax; dilution, 1:4,000; cat. no. ab32503), cytochrome *c* (cyt c; dilution, 1:4,000; cat. no. ab76237) and β-actin (dilution, 1:4,000; cat. no. ab16039) primary antibodies were purchased from Abcam (Cambridge, England). A horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (dilution 1:80,000; cat. no. IH-0011) was obtained from Wuhan Boster Biological Technology, Ltd. (Wuhan, China). All other chemicals were obtained from Nanjing Jiancheng Bio Institute (Nanjing, China).

POA was provided by the South China Sea Institute of Oceanology (Guangzhou, China). The structure of POA was elucidated by infrared (IR), nuclear magnetic resonance and mass spectrometry (MS) analyses, and its \>98% purity was determined by high performance liquid chromatography (HPLC) ([@b8-mmr-17-01-0743]). POA was dissolved in DMSO and during the experiments, the DMSO content in the medium never exceeded 0.5% (v/v).

### Cell culture

L-02 cells were derived from healthy adult human livers and obtained from the Guangzhou Jennio Biotech Co., Ltd. (Guangzhou, China). Cells were maintained in RPMI 1640 media supplemented with 10% heat-inactivated FBS at 37°C in 5% CO~2.~ The cells were cultured for 3 days and culture medium was changed every 2 days. Cells for assay were detached by a solution of 0.25% trypsin and 0.02% EDTA.

### Assessment of cell viability

L-02 cells (1×10^4^ cells/well) were seeded into 96-well microplates and exposed to various concentrations of POA (10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 µM) for 24, 48 or 72 h. Cells treated without POA (0 µM) served as a control in each experiment throughout the study. Subsequently, cells were incubated with 10 µl CCK-8 for 2 h, which provided effective and reproducible determination of the proliferative activity of L-02, as the dehydrogenases in surviving cells can convert CCK-8 to a colored formazan product. Finally, the optical density was measured at a wavelength of 450 nm using a microplate reader (PerkinElmer, Inc., Waltham, MA, USA) with a reference wavelength of 650 nm. Three independent experiments were conducted in triplicate.

### Assessment of morphological changes in the cell and nucleus

The morphologies of the L-02 cells after exposure to 20 or 40 µM POA for 24 h were evaluated under a phase contrast optical microscope (Leica Microsystems GmbH, Wetzlar, Germany). The morphological changes in the L-02 cells induced by POA were examined by fluorescent visualization under a fluorescence microscope (Leica, Microsystems GmbH). Briefly, cells were treated similarly as described above, then washed twice with PBS, fixed with 4% paraformaldehyde for 10 min and incubated with Hoechst 33258 fluorescent dye (5 mg/ml) for 5 min. Following this, cells were washed with PBS, dried, observed and imaged under a fluorescence microscope.

### Assessment of apoptosis by the Annexin V/PI staining assay

POA-induced apoptosis was measured by Annexin V-FITC/PI double staining using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA). In brief, subsequent to either sham (0 µM) or POA exposure (10, 20 or 40 µM) for 6 h, L-02 cells were harvested and washed twice with pre-cooled PBS, and resuspended with 500 µl binding buffer, 5 µl Annexin V-FITC conjugate and 5 µl PI buffer, according to manufacturer\'s protocol. Cells were incubated in the dark for 15 min at room temperature, following which they were analyzed by flow cytometry, with each determination based on the acquisition of 10,000 events. The percentage of early apoptotic cells was calculated with the ratio of the total L-02 cell number.

For PI staining, cells were treated as described above, collected and centrifuged (800 × g for 5 min at 4°C), washed twice with ice-cold PBS, then fixed in 70% chilled ethanol for 12 h. After fixation, L-02 cells were washed and incubated in PBS containing 50 mg/ml PI, 1 mg/ml RNase A and Triton X-100 (0.5%) at 4°C for 30 min in the dark according to the instructions provided by the cell-cycle kit. Finally, the cells were assessed using a FACScan flow cytometer, and the percentage of nuclei with sub-G1 content was considered as apoptotic cells. The results were counted by a blind observer.

### Activity of caspase 3

The activity of caspase 3 was measured by a caspase 3 activity assay kit. In brief, the cells were treated either sham or POA (10, 20 or 40 µM) for 24 h, following which cells were harvested, washed twice with ice-cold PBS and resuspended in cold lysis buffer for 60 min at 4°C. The lysate was centrifuged (12,000 × g, 4°C, 5 min) and the supernatant was incubated with the enzyme specific colorimetric substrate Ac-DEVD-pNA in assay buffer for 2 h at 37°C. The colorimetric release of pNA from the Ac-DEVD-pNA substrate was examined using a microplate reader (PerkinElmer, Inc.) with the optical absorbance at 405 nm.

### Protein expression levels of Fas, Bax and Bcl-2

The cytosolic fractions of Fas, Bax and Bcl-2 were extracted from the cell with RIPA lysis buffer containing 1% phenylmethanesulfonyl fluoride (PMSF), and the expression levels were detected by western blotting. Briefly, subsequent to either sham or POA exposure (20 or 40 µM for 24 h), 5×10^6^ cells were trypsinized and harvested, then the treated cells were lysed in precooled lysis buffer and incubated on ice for 30 min. The homogenate was centrifuged at 8,000 × g for 8 min at 4°C, and the supernatant was transferred to an ice-cold 1.5 ml tube and stored at −20°C until further use. The concentration of total protein in the supernatant was determined by the BCA protein assay kit. Proteins (60 µg/lane) were separated by 12% SDS-PAGE for 90 min, and then were electrotransferred to a polyvinylidene difluoride membrane. Membranes were subsequently incubated with Fas, Bax and Bcl-2 primary antibodies, followed by incubation with corresponding HRP-conjugated secondary antibodies. Fas, Bax and Bcl-2 expressions were then detected using an ECL kit (Beyotime Institute of Biotechnology, Jiangsu, China) and analyzed by Gel. Doc2000 Gel imager (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with Image Lab Software version 3.0 (Bio-Rad Laboratories, Inc.).

### Assessment of oxidation state

To detect intracellular oxidation state, L-02 cells were treated as described above, but in 6-well plates. Subsequently, the harvested cell suspension was washed with PBS (pH 7.4), sonicated (20 sec) in ice, and then centrifuged at 5,000 × g for 10 min at 4°C. The supernatant was transferred to fresh tubes and used for the enzymatic assays.

### GSH content

The antioxidant enzyme GSH was measured by a GSH ELISA kit. The samples were prepared similarly as described above, according to the manufacturer\'s protocol. The assay is based on the depth of yellow, which is inversely associated with the content of GSH. The content of GSH was determined by measuring the optical absorbance at a wavelength 450 nm using a microplate reader (PerkinElmer, Inc.) Activity of GSH is expressed as µg/ml protein.

### Superoxide dismutase (SOD) activity

The activity of SOD was measured by the reduction of the formation of reddish violet crystals using a microplate reader at a wavelength of 550 nm, then the precise result was obtained through the formula calculation of the manufacturer\'s protocol based on cellular protein concentration. Protein concentrations were determined by using a formula calculation based on absorbance values at 550 nm ([@b10-mmr-17-01-0743]). Activity of SOD is expressed as U/mg protein.

### Determination of lipid peroxidation

The content of malondialdehyde (MDA) was measured by a MDA detection kit (Nanjing Jiancheng Bio Institute) according to the manufacturer\'s protocol. MDA reacts with thiobarbituric acid (TBA) at 95--100°C in acidic conditions and produces a pink colored MDA-TBA conjugate, which has an absorbance at a wavelength of 532 nm using a microplate reader. MDA was calculated based on cellular protein concentration. Cellular MDA is expressed nmol/mg cellular protein.

### Assessment of nitric oxide (NO)

The content of NO was measured by a NO detection kit (Nanjing Jiancheng Bio Institute), which conducted following the manufacturer\'s protocol. NO reacts with oxygen and water is converted into nitrate and nitrite, which can change to a pink azo compound in a nitrate chromogenic agent. NO levels were determined by measuring the optical density of colored formation at 550 nm with a microplate reader. NO content was calculated based on cellular protein concentration, with sodium nitrite to generate the standard curve. Cellular NO content is expressed µmol/g cellular protein.

### Measurement of alanine aminotransferase (ALT) and aspartate aminotransferase (AST)

The levels of ALT and AST were calculated using ALT and AST detection kits (Nanjing Jiancheng Bio Institute), according to the manufacturers\' protocol. The absorbance was measured at a wavelength of 510 nm with a microplate reader. Cellular ALT and AST contents are expressed U/mg cellular protein with pyruvic acid sodium to generate the standard curve.

### Lactate dehydrogenase (LDH) leakage assay

The LDH leakage assay was assessed by a LDH cytotoxicity detection ELISA kit (cat. no. CSB-E11720h; CUSABIO Biotech. Co., Ltd., Wuhan, China) according to the manufacturer\'s protocol. The concentration of LDH was determined by measuring the optical density at 450 nm with a microplate reader according to the standard curve, and the calculation was based on cellular protein concentration.

### Measurement of reactive oxygen species (ROS) production

ROS accumulation in cells was measured by a ROS detection kit (Nanjing Jiancheng Bio Institute) using the cell permeable fluorescent dye 2,7-dichlorofluorescin diacetate (DCFH-DA). The intracellular esterases hydrolyze DCFH-DA to DCFH, which is oxidized to DCF by the oxidants; its fluorescence is a measure of ROS production in the cell. A BD flow cytometer with BD CFlow software v.264.15 (BD Biosciences) was used to measure the fluorescence intensity at excitation and emission wavelengths of 485 and 530 nm, respectively.

### Assessment of mitochondrial membrane potential (MMP)

To monitor the loss of MMP, L-02 cells (5×10^5^ cells/ml) in 6-well culture plates were treated without or with POA (10, 20 or 40 µM) for 24 h. Reaction medium (pH 7.4) containing 5 µg/ml JC-1 cationic dye were preincubated at 37°C. Cells were trypsinized and harvested, washed twice with ice-cold PBS, then incubated with reaction medium for 30 min in darkness at 37°C. Finally, cells were washed twice with PBS then analyzed by flow cytometry as described above, within 1 h.

### Assessment of adenosine triphosphate (ATP)

The ATP level was determined using an ATP detection kit (Nanjing Jiancheng Bio Institute) according to the manufacturer\'s protocol. In brief, L-02 cells were treated without or with POA (10, 20 or 40 µM) for 24 h, then cells were harvested and centrifuged (2,400 × g, 5 min, 4°C), and the cell pellet was ultrasonicated for 5 sec. The optical density was detected at a wavelength of 660 nm with a microplate reader and the concentration was calculated according to the standard curve, based on cellular protein concentration. Cellular ATP content is expressed as U/mg cellular protein.

### Assessment of mitochondrial permeability transition pore (MPTP)

The MPTP was determined with a MPTP kit (Nanjing Jiancheng Bio Institute) according to the manufacturer\'s protocol. Mitochondrial relative fluorescence intensity as an indicator of MPTP was estimated from the decrease using an excitation wavelength of 480 nm and an emission wavelength of 530 nm. Data are reported as fold in fluorescence intensity relative to the control.

### Assessment of the release of cyt c from mitochondria

The cytosolic fraction of cyt c was extracted from the cell with RIPA lysis buffer containing 1% PMSF and detected by western blotting. Briefly, L-02 cells were treated without or with POA (20 or 40 µM for 24 h), 5×10^6^ cells were trypsinized and harvested, and the treated cells were lysed in precooled lysis buffer on ice for 30 min. The homogenate was centrifuged at 8,000 × g for 8 min at 4°C, and the supernatant was transferred to an ice-cold 1.5 ml tube and stored at −20°C until further use. The protein concentration in the supernatant was determined by the BCA protein assay kit. Equal amounts of protein (60 µg/lane) were separated by 12% SDS-PAGE and were electrotransferred to a polyvinylidene difluoride membrane. The membrane was then incubated in 5% non-fat milk in TBS with Tween-20 (TBST) for 2 h followed by overnight incubation with the cytochrome *c* antibody at 4°C. The incubated membrane was washed with TBST before incubation for 1 h with a HRP-conjugated goat anti-rabbit IgG secondary antibody at 25°C. Membranes were washed with TBST, and proteins were detected by an ECL kit (Beyotime Institute of Biotechnology, Jiangsu, China) and analyzed by Gel. Doc2000 Gel imager (Bio-Rad Laboratories, Inc.) with Image Lab Software version 3.0 (Bio-Rad Laboratories, Inc.).

### Electron microscopy of mitochondria

The morphological changes of mitochondria were observed by electron microscopy assay. In brief, L-02 cells were exposed to POA (0, 10, 20 or 40 µM for 24 h), then trypsinized and harvested for transmission electron microscopy. Cells samples of a maximum size of 1 mm^3^ were collected and prefixed in PBS (pH 7.2) supplemented with 2.5% glutaraldehyde for 4 h, according to a method described previously ([@b11-mmr-17-01-0743]). Finally, the sections were observed under a transmission electron microscope.

### Statistical analysis

Values are presented as the mean ± standard deviation of at least three independent experiments. Statistical differences were analyzed by one way analysis of using SPSS version 17.0 software (SPSS, Inc., Chicago, IL, USA). Student\'s t-test was used for comparison between two groups. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Cytotoxicity induced by POA in L-02 cells

The cytotoxicity of POA in L-02 cells was determined using the CCK-8 assay, which is a sensitive, quantitative and reliable method to analyze cell viability and cell growth. The cell growth inhibition after treatments with various concentrations of POA for 24, 48 or 72 h is presented in [Fig. 2](#f2-mmr-17-01-0743){ref-type="fig"}. As expected, in comparison with the control cells, POA significantly decreased L-02 cell viability in a typical dose- and time-dependent manner (P\<0.01 vs. control). DMSO alone did not show any inhibitory effect on the cell viability.

### Morphological changes induced by POA in L-02 cells

As presented in [Fig. 3A](#f3-mmr-17-01-0743){ref-type="fig"}, in the absence of POA, L-02 cells had a common spindle shape, whereas POA treatment (20 and 40 µM) resulted in increased shrinkage and detachment from the substrate as the exposure dose increased ([Fig. 3A](#f3-mmr-17-01-0743){ref-type="fig"}). After the treatments, the L-02 cells were stained with Hoechst 33258 and visualized to investigate the incidence of apoptosis. As presented in [Fig. 3B](#f3-mmr-17-01-0743){ref-type="fig"}, in the absence of POA, the L-02 cells had almost uniform Hoechst 33258 (blue) staining with intact nuclei, and appeared to proliferate in spindle-like shapes in the wells. While in the presence of POA (20 and 40 µM), the apoptotic cells were characterized by brighter blue with nuclear condensation and chromatin margination in a dose-dependent manner, indicating an increased apoptosis in these cells ([Fig. 3B](#f3-mmr-17-01-0743){ref-type="fig"}).

### Effects of POA on early apoptosis and cell cycle in L-02 cells

As presented in [Fig. 4A](#f4-mmr-17-01-0743){ref-type="fig"}, when L-02 cells were treated with 0, 10, 20 or 40 µM POA for 6 h, significant increases in the percentage of early apoptotic cells (Annexin V^+^/PI^−^ staining) were observed, with increases from 4.0% at 0 µM, to 10.5% at 10 µM, 16.4% at 20 µM and 20.1% at 40 µM. The inhibitory effect of POA on L-02 cell growth was further investigated using flow cytometric analysis. The amounts of apoptotic cells were determined by the sub-G1 apoptotic peaks, which may be attributed to their lower cellular DNA content in case of DNA crazing. Apoptotic peaks and the distributions of the cells in various phases of the cell cycle were observed after 24 h treatment with POA (10, 20 and 40 µM). As presented in [Fig. 4B](#f4-mmr-17-01-0743){ref-type="fig"}, POA induced an increase in sub-G1 apoptotic peaks and S-phase cell populations in a dose-dependent manner, indicating an accelerated cell cycle. The result was accompanied by a marked increase of the percentage of cells in the G2/M phase, while the percentage of cells in the G1 phase exhibited a significant reduction. The results of Annexin V-PI double-labeling assay and cell-cycle analysis indicated that growth inhibition was accompanied with an increase in apoptotic cells in a dose-dependent manner.

### Effect of POA on caspase 3 activity in L-02 cells

Caspase 3 mainly exists in the cytoplasm in normal state; during apoptosis, it is energized into two large and two small subunit compositions, which can break the cytoplasm and nucleus, eventually leading to apoptosis. As presented in [Fig. 4C](#f4-mmr-17-01-0743){ref-type="fig"}, when L-02 cells were exposed to POA (10, 20 and 40 µM) for 24 h, the activities of caspase 3 were significantly increased (P\<0.01) in a concentration-dependent manner, compared with cells treated without POA.

### Effect of POA on levels of apoptotic proteins in L-02 cells

As presented in [Fig. 5A and B](#f5-mmr-17-01-0743){ref-type="fig"}, POA (0, 20 or 40 µM) treatment for 24 h increased the protein expression of Fas compared with the control (0 µM). Additionally, the protein expression of Bcl-2 decreased with exposure to POA at increasing concentrations (0, 20 and 40 µM), while that of Bax increased in POA-treated cells in comparison with control cells. The results of the expression levels of apoptotic proteins indicated that POA may upregulate the expression levels of Fas and Bax, and downregulate Bcl-2 expression, in a concentration-dependent manner.

### Effects of POA on oxidative stress

GSH is a ubiquitous sulfhydryl-containing molecule in cells that is responsible for maintaining cellular oxidation-reduction homeostasis. Changes in GSH homeostasis can be monitored as an indication of cell damage. As presented in [Fig. 6A](#f6-mmr-17-01-0743){ref-type="fig"}, POA induced a decrease in the level of GSH. The levels of GSH were 0.932-fold at 10 µM, 0.821-fold at 20 µM and 0.719-fold at 40 µM of control, respectively. Compared with the control (44.03 U/ml), POA markedly decreased SOD activity to 37.31 U/ml at 10 µM, 32.73 U/ml at 20 µM and 30.72 U/ml at 40 µM ([Fig. 6B](#f6-mmr-17-01-0743){ref-type="fig"}). Additionally, POA induced a significant increase in the level of MDA from 0.57 nmol/mg at 0 µM to 0.71 nmol/mg at 10 µM and 0.79 nmol/mg at 20 µM (P\<0.05 vs. control) and 1.36 nmol/mg at 40 µM (P\<0.001 vs control; [Fig. 4C](#f4-mmr-17-01-0743){ref-type="fig"}). Furthermore, POA inhibited NO production in a dose-dependent manner, from 21.43 µmol/l in control cells to 13.41, 8.94 and 3.14 µmol/l after 10, 20 and 40 µM POA, respectively ([Fig. 4D](#f4-mmr-17-01-0743){ref-type="fig"}).

The results indicated that POA increased the activities of ALT ([Fig. 6E](#f6-mmr-17-01-0743){ref-type="fig"}) and AST ([Fig. 6F](#f6-mmr-17-01-0743){ref-type="fig"}) in a dose-dependent manner. The ALT level was increased to 2.38, 3.99, 5.87 U/g protein compared with the control (0.65 U/g protein), and AST levels were increased to 2.75, 6.25, 8.43 compared with the control (1.75 U/g protein) in cells treated with 10, 20 and 40 µM for 24 h, respectively.

Membrane damage that leads to LDH leakage is generally considered irreversible. Thus, LDH leakage was applied to as a biomarker for cellular viability. As presented in [Fig. 6G](#f6-mmr-17-01-0743){ref-type="fig"}, LDH leakage was identified in POA-induced L-02 cells in a dose dependent manner: 1.48-fold at 10 µM, 2.08-fold at 20 µM and 3.06-fold at 40 µM compared with control cells.

### Effect of POA on ROS production in L-02 cells

DCFH-DA is generally used to measure ROS generation in cells. As presented in [Fig. 7](#f7-mmr-17-01-0743){ref-type="fig"}, ROS production following a 24-h exposure to POA increased in a concentration-dependent manner. The level of ROS in L-02 cells increased from 4.2% at 0 µM to 14.2% at 10 µM, 19.5% at 20 µM and 23.1% at 40 µM.

### Effects of POA on mitochondrial function in L-02 cells

MMP was determined by the uptake of JC-1 (a molecular probe) using flow cytometric assay. As presented in [Fig. 8A](#f8-mmr-17-01-0743){ref-type="fig"}, MMP depolarization following a 24-h exposure to POA (10, 20 and 40 µM) significantly increased in a dose-dependent manner. The percentage of depolarized cells were 14.2, 19.5 and 23.1% in the samples treated with 10, 20 and 40 µM, respectively, while the value in control cells was 4.2%. Therefore, POA-induced mitochondrial damage resulted in disruption of MMP.

Concentrations of ATP in L-02 cells treated with POA are presented in [Fig. 8B](#f8-mmr-17-01-0743){ref-type="fig"}. The ATP level decreased from 1.85 U/mg at 0 µM to 1.39 U/mg at 10 µM, 0.81 U/mg at 20 µM and 0.50 U/mg at 40 µM, which indicated that POA induced the decrease of ATP in a dose-dependent manner.

The results of the MPTP assay are presented in [Fig. 8C](#f8-mmr-17-01-0743){ref-type="fig"}. The relative fluorescence intensity decreased compared with the control in a dose-dependent manner, and was 0.78 at 10 µM, 0.60 at 20 µM and 0.41 at 40 µM. This suggested an increasing number of cells with mitochondrial membrane depolarization or breakdown.

### Effects of POA on cyt c

As presented in [Fig. 9](#f9-mmr-17-01-0743){ref-type="fig"}, POA treatment significantly increased the protein expression levels of cyt *c* compared with control cells (P\<0.001 vs. control), which in parallel with mitochondrial membrane breakdown, indicated that POA increases the release of the cyt *c* protein from the mitochondria into the cytosol.

### Electron microscopy findings

A transmission electron microscope was used to observe the cell mitochondrial internal structure. In L-02 cells there were lesions in the mitochondria of POA treated cells compared to sham treated cells. In the blank control group, mitochondrial structures had a regular shape, were distributed in cells regularly and mitochondrial crests were arranged by rule ([Fig. 10A](#f10-mmr-17-01-0743){ref-type="fig"}), whereas cells treated with 10 ([Fig. 10B](#f10-mmr-17-01-0743){ref-type="fig"}), 20 ([Fig. 10C](#f10-mmr-17-01-0743){ref-type="fig"}) and 40 µM ([Fig. 10D](#f10-mmr-17-01-0743){ref-type="fig"}) POA exhibited increased vacuole sizes, mitochondrial swelling and disappearance of mitochondrial matrix particles. Furthermore, the areas of vacuoles increased to more than half than that of the mitochondria, and integrated mitochondria around the nucleus were rare as the dose increased.

Discussion
==========

POA was isolated from a culture broth of the South China Sea fungus *Penicillium oxalicum* SCSGAF 0023 ([@b8-mmr-17-01-0743]). Although POA has previously been indicated to induce cytotoxicity in human carcinoma ([@b12-mmr-17-01-0743]), to the best of our knowledge, there have not been previous studies on the cytotoxicity of POA on L-02 cells human normal liver cells, which has been a major limitation in the clinical application of POA. The present study investigated POA-induced cytotoxicity and its toxic mechanisms in L-02 cells. It was demonstrated that the toxicological mechanisms of POA on human normal liver cells mainly included oxidative stress injury and mitochondrial dysfunction.

In the CCK-8 assay of cell viability, POA inhibited the proliferation of L-02 cells in a concentration- and time-dependent manner, which demonstrated that POA induced cytotoxicity in L-02 cells. POA inhibited L-02 cell proliferation, potentially via apoptosis-associated processes. Apoptosis, a highly structured and ordered process, eliminates superfluous, harmful and metabolically perturbed cells, and is a fundamental form of cell death ([@b13-mmr-17-01-0743]). In the present study, apoptosis was induced by POA in L-02 cells, as evidenced by typical morphological changes in the cell and nucleus assayed by Hoechest 33258 staining, such as karyopyknosis, deepened stains and karyorrhexis, along with cellular shrinkage, chromatin condensation, nuclear fragmentation shrinkage and nuclear condensation or fragmentation. Furthermore, Annexin V/PI double staining and cell cycle arrest assays further confirmed apoptosis by flow cytometry; they demonstrated that POA markedly and progressively increased the percentage of early apoptosis of the cells as the concentration increased, compared with the control. Meanwhile, POA largely increased the sub-G1 cell population in a whole cell cycle, which is a hallmark of apoptosis ([@b14-mmr-17-01-0743]), along with causing S-phase arrest. Additionally, POA was able to activate caspase 3, which is a key executioner of apoptosis ([@b15-mmr-17-01-0743]), thus providing a reasonable explanation for cytotoxic activities in L-02 cells induced by POA, directly demonstrating that the mechanism of cytotoxicity is associated with the apoptosis.

To elucidate the molecular toxic mechanism of the POA, the expression of apoptosis proteins were detected, including Fas, Bax and Bcl-2. It has previously been reported that the extrinsic apoptotic signaling pathway is initiated by binding of the Fas ligand to the ectodomain of the surface death receptor Fas protein, which triggers activation of caspases that induce cell death ([@b16-mmr-17-01-0743],[@b17-mmr-17-01-0743]). Thus, Fas serves an important role in the initiation of the cell death signaling pathway ([@b18-mmr-17-01-0743]). The present study identified that POA promoted the expression of Fas protein, which further demonstrated that POA induced apoptosis in L-02 cells in accordance with the results described above, potentially via the intrinsic signaling apoptotic pathway.

The Bcl-2 family, which serves a key role in deciding the fate of cells, can be divided into either anti-apoptotic or pro-apoptotic members ([@b19-mmr-17-01-0743]). Apoptosis is also understood to be critically dependent on the balance between the Bax and the Bcl-2 proteins ([@b20-mmr-17-01-0743],[@b21-mmr-17-01-0743]). Therefore, the expression levels of Bax and Bcl-2 were detected by western blotting. The results indicated that POA increased the expression of the pro-apoptotic protein Bax and decreased the expression of anti-apoptotic protein Bcl-2, suggesting that POA may alter the balance between anti- and pro-apoptotic protein members, ultimately inducing apoptosis in L-02 cells involving the Bcl-2 family protein.

Oxidative stress serves a role in the mechanisms of toxicity in a number of compounds, whether by production of free radicals or by depletion of cellular antioxidant capacity. Cellular integrity is affected by oxidative stress when the production of reactive oxidants overwhelms antioxidant defense mechanisms. The disruption of cellular redox balance by exogenous substances may lead to cell damage. GSH, non-enzymatic substance, is an omnipresent sulfhydryl-containing molecule in cells, which is responsible for maintaining cellular oxidation-reduction homeostasis and changes in the homeostasis that are as a sign of cell damage ([@b22-mmr-17-01-0743]). SOD is a ubiquitous component of cellular antioxidant systems, which can convert superoxide anions to hydrogen peroxide and fight the damage resulting from the oxygen free radical to cells, rapidly repairing damaged cells. The present study demonstrated that POA reduced the content of GSH and the activity of SOD. These results indicated that the GSH and SOD antioxidant system is involved in POA-induced oxidative stress injury in L-02 cells. It has been reported that the promotion of MDA, which is the main end production of lipid peroxidation, is an indication of membrane lipid damage, as membrane lipids are major targets of free radicals ([@b23-mmr-17-01-0743]). On the other hand, NO is a free radical, which takes part in many pathological processes; a small amount of NO serves a physiological role, whereas a large amount of NO induces cell damages. The present study revealed that POA elevated MDA and NO levels, which suggested that POA induced lipid peroxidation injury in L-02 cells, and the oxidative stress served an important role in POA-induced cytotoxicity.

ALT and AST mainly exist in liver cells, and translocate to the outer membrane from the interior once necrosis or liver damage occur. They are sensitive indicators for the examination of liver function in clinical treatment, and are used to assess the damage of liver cells. The present study demonstrated an increase in levels of ALT and AST in comparison with the control, which revealed that POA induced damage in L-02 cells. Similarly, LDH is a glycolytic enzyme that exists in the cytoplasm of cells; when cells are damaged, it leaks from the interior to the outer of cells. The LDH leakage test indicated that the amount of LDH in treatments was increased compared with the sham, which indicated that POA induced damage in L-02 cells, consistent with ALT and AST results.

ROS are by-products of biological redox reactions and are associated with various pathological conditions. They increase following exposure to harmful substances and rely on the balance between oxidative and antioxidant cellular system ([@b24-mmr-17-01-0743]). In turn, excessive harmful substances can disturb this balance by creating increased formation of ROS through mitochondria dysfunction or diminishing and/or inhibiting antioxidant system, and the overproduction of ROS may induce apoptosis and cell death ([@b25-mmr-17-01-0743]). The present study demonstrated that POA significantly increased ROS production in a dose-dependent manner, which is consistent with the above results of cytotoxicity and oxidative stress injury induced by POA in L-02 cells.

Mitochondria serve a key role in apoptosis, and the mitochondrial apoptotic pathway has been suggested as a pivotal signaling pathway of apoptosis ([@b26-mmr-17-01-0743]). The most crucial effect of oxidant stress is the increased opening of the MPTP, resulting in the collapse of membrane potential and interruption of ATP synthesis ([@b27-mmr-17-01-0743]). Certain drugs can lead swollen mitochondria, abnormal or cracked cristae and reduced matrix density in liver cells. The MMP formed by electrons within the mitochondrial respiratory chain couples with the extrusion of protons from the mitochondrial matrix to the intermembrane space, which is the driving force for phosphorylation of ADP in the process of oxidative phosphorylation ([@b28-mmr-17-01-0743]). A previous study confirmed that the depolarization of MMP is an irreversible cause of early apoptosis ([@b29-mmr-17-01-0743]). In the present study, incubation of activated mitochondria with POA resulted in an abrupt depletion of ATP synthesis, MPTP opening and mitochondria swelling, vacuolation, and reduced matrix density. Furthermore, POA induced the depletion of MMP; as it is reported that alternations in the mitochondrial functions via the increase of ROS generation and disruption of MMP may lead to cell death ([@b30-mmr-17-01-0743]), these results indicated that POA induced damage in mitochondria, thus causing cytotoxicity in L-02 cells. Furthermore, the exposure of L-02 cells to POA resulted in an abrupt release of cyt *c* in comparison to control, indicating an impairment of mitochondrial function.

In conclusion, the present study demonstrated that POA may lead to persistent toxicity in L-02 cells. The mechanisms of POA-mediated hepatocellular toxicity potentially involve apoptosis via oxidative stress injury and impairment of mitochondrial function in L-02 cells. The alteration of mitochondrial function and oxidative stress may be the major cause for the activation of the caspase cascade that results in apoptosis in response to POA-induced hepatocellular toxicity. However, whether other mechanisms are associated with POA-induced cytotoxicity remain to be further investigated.
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![Chemical structure of oxalicumone A.](MMR-17-01-0743-g00){#f1-mmr-17-01-0743}

![Concentration- and time-dependent inhibition effect of POA in L-02 cells. L-02 cells were treated with 0, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 µM POA for 24, 48 or 72 h. Data are presented as the mean ± standard deviation from three independent experiments. \*P\<0.01 vs. 24 h at each concentration. POA, oxalicumone A.](MMR-17-01-0743-g01){#f2-mmr-17-01-0743}

![Morphological changes in L-02 cells and nuclei in response to oxalicumone A treatment for 24 h. (A) Phase contrast images of L-02 cells following various treatments (magnification, ×100). (B) Fluorescence photomicrograph of L-02 cells stained with Hoechst 33258 following various treatments (magnification, ×100).](MMR-17-01-0743-g02){#f3-mmr-17-01-0743}

![(A) The percentage of apoptotic cells analyzed by flow cytometric analysis of Annexin V FITC/PI double staining. (B) The percentage of cell cycle phase was analyzed by flow cytometry analysis. (C) Activity of caspase 3 in L-02 cells after treatment with or without (control) POA. Data are presented as the mean ± standard deviation from three independent experiments. \*\*P\<0.01, \*\*\*P\<0.001. FITC, fluorescein isothiocyanate; PI, propidium iodide; POA, oxalicumone A.](MMR-17-01-0743-g03){#f4-mmr-17-01-0743}

![Effect of oxalicumone A on protein expression levels of Fas, Bax and Bcl-2 in L-02 cells. β-actin served as internal control. (A) Representative western blot images and (B) quantification from at least three experiments. Data are presented as the mean ± standard deviation. \*\*P\<0.01, \*\*\*P\<0.001. Fas, Fas ligand; Bax, B-cell lymphoma 2 X-associated protein; Bcl-2, B-cell lymphoma 2.](MMR-17-01-0743-g04){#f5-mmr-17-01-0743}

![Effect of POA on (A) GSH activity, (B) SOD activity, (C) MDA formation, (D) NO content, (E) ALT content, (F) AST content and (G) LDH content in L-02 cells. Data are presented as the mean ± standard deviation. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001. GSH, glutathione; MDA, malondialdehyde; NO, nitric oxide; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; SOD, superoxide dismutase; POA, oxalicumone A.](MMR-17-01-0743-g05){#f6-mmr-17-01-0743}

![Effect of oxalicumone A on reactive oxygen species production in L-02 cells.](MMR-17-01-0743-g06){#f7-mmr-17-01-0743}

![Effects of POA on (A) MMP, (B) ATP and (C) MPTP in L-02 cells. Data are presented as the mean ± standard deviation. \*\*\*P\<0.001. MMP, mitochondrial membrane potential; ATP, adenosine triphosphate; MPTP, mitochondrial permeability transition pore; POA, oxalicumone A; JC-1, 5,5,6,6-tetra-chloro-1,1,3,3-tetraethylbenzimidazolyl-carbocyanine iodide.](MMR-17-01-0743-g07){#f8-mmr-17-01-0743}

![Effect of POA on expression levels of cyt *c* in L-02 cells. β-actin served as an internal control. (A) Representative western blot images and (B) quantification from at least three experiments. Data are presented as the mean ± standard deviation. \*\*\*P\<0.001. Cyt *c*, cytochrome *c*; POA, oxalicumone A.](MMR-17-01-0743-g08){#f9-mmr-17-01-0743}

![Effects of POA on mitochondria in L-02 cells, as assessed by transmission electron microscopy observation (magnification, ×10,000). (A) Control; (B) 10 µM, (C) 20 µM and (D) 40 µM POA treatment. N, cell nucleus; M, mitochondria; POA, oxalicumone A.](MMR-17-01-0743-g09){#f10-mmr-17-01-0743}
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